Compare DRS & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRS | COO |
|---|---|---|
| Founded | 1969 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 13.7B |
| IPO Year | 2021 | 1994 |
| Metric | DRS | COO |
|---|---|---|
| Price | $45.30 | $76.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | $49.33 | ★ $90.18 |
| AVG Volume (30 Days) | 817.9K | ★ 1.9M |
| Earning Date | 05-05-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 28.75 | N/A |
| EPS | ★ 0.55 | 0.27 |
| Revenue | ★ $3,648,000,000.00 | $2,532,800,000.00 |
| Revenue This Year | $8.14 | $6.66 |
| Revenue Next Year | $6.54 | $5.18 |
| P/E Ratio | ★ $81.33 | $283.78 |
| Revenue Growth | 12.80 | ★ 18.41 |
| 52 Week Low | $32.43 | $58.89 |
| 52 Week High | $50.59 | $89.83 |
| Indicator | DRS | COO |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 66.80 |
| Support Level | $43.23 | $68.47 |
| Resistance Level | $47.26 | $84.38 |
| Average True Range (ATR) | 1.78 | 1.48 |
| MACD | -0.18 | 0.25 |
| Stochastic Oscillator | 20.07 | 86.69 |
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. It is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.